Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Gual

Showing results (61-70 of 218) with videos related to

Pageof 22
Sort By:
Clinical Drug Investigation|February 27, 2018
Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?Pablo Barrio, Lluisa Ortega, Josep Guardia, et al.
Medicina Clinica|March 3, 2006
[Alcoholism and immigration. Adherence of immigrant patients to group therapy]Miquel Monras, Neus Freixa, Lluisa Ortega, et al.
Adicciones|March 15, 2013
Alcohol consumption, alcohol dependence and related harms in Spain, and the effect of treatment-based interventions on alcohol dependenceJürgen Rehm, Maximilien X Rehm, Kevin D Shield, et al.
Journal of Psychopharmacology (Oxford, England)|March 28, 2014
Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled studyWim van den Brink, Per Sørensen, Lars Torup, et al.
European Addiction Research|August 23, 2018
A Survey on the Medical Use of Cannabis in Europe: A Position PaperJørgen G Bramness, Geert Dom, Antoni Gual, et al.
Biological Psychiatry|December 15, 2012
Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefeneKarl Mann, Anna Bladström, Lars Torup, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|August 1, 2013
Wernicke-Korsakoff's syndrome: waiting for Godot?Carlos Soler-González, Joaquín Sáez-Peñataro, Mercè Balcells-Oliveró, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 9, 2013
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependenceAntoni Gual, Yuan He, Lars Torup, et al.
Journal of Clinical Medicine|April 10, 2019
The More You Take It, the Better It Works: Six-Month Results of a Nalmefene Phase-IV TrialPablo Barrio, Carlos Roncero, Lluisa Ortega, et al.
Frontiers in Digital Health|February 23, 2023
Editorial: Using digital solutions for Brief Interventions in Alcohol, Tobacco, other drug use, and gambling: From the present to the futureHugo López-Pelayo, Elsa Caballeria, Antoni Gual, et al.
Pageof 22

Showing results (61-70 of 218) with videos related to

Sort By:
Pageof 22
Clinical Drug Investigation|February 27, 2018
Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?Pablo Barrio, Lluisa Ortega, Josep Guardia, et al.
Medicina Clinica|March 3, 2006
[Alcoholism and immigration. Adherence of immigrant patients to group therapy]Miquel Monras, Neus Freixa, Lluisa Ortega, et al.
Adicciones|March 15, 2013
Alcohol consumption, alcohol dependence and related harms in Spain, and the effect of treatment-based interventions on alcohol dependenceJürgen Rehm, Maximilien X Rehm, Kevin D Shield, et al.
Journal of Psychopharmacology (Oxford, England)|March 28, 2014
Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled studyWim van den Brink, Per Sørensen, Lars Torup, et al.
European Addiction Research|August 23, 2018
A Survey on the Medical Use of Cannabis in Europe: A Position PaperJørgen G Bramness, Geert Dom, Antoni Gual, et al.
Biological Psychiatry|December 15, 2012
Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefeneKarl Mann, Anna Bladström, Lars Torup, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|August 1, 2013
Wernicke-Korsakoff's syndrome: waiting for Godot?Carlos Soler-González, Joaquín Sáez-Peñataro, Mercè Balcells-Oliveró, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 9, 2013
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependenceAntoni Gual, Yuan He, Lars Torup, et al.
Journal of Clinical Medicine|April 10, 2019
The More You Take It, the Better It Works: Six-Month Results of a Nalmefene Phase-IV TrialPablo Barrio, Carlos Roncero, Lluisa Ortega, et al.
Frontiers in Digital Health|February 23, 2023
Editorial: Using digital solutions for Brief Interventions in Alcohol, Tobacco, other drug use, and gambling: From the present to the futureHugo López-Pelayo, Elsa Caballeria, Antoni Gual, et al.
Pageof 22